Moehler, Markus; Dvorkin, Mikhail; Boku, Narikazu et al.
Phase III Trial of Avelumab Maintenance After First-Line Induction Chemotherapy Versus Continuation of Chemotherapy in Patients With Gastric Cancers: Results From JAVELIN Gastric 100JOURNAL OF CLINICAL ONCOLOGY. Bd. 39. H. 9. 2021
Meric-Bernstam, F.; Furuse, J.; Oh, D-Y. et al.
Pooled analysis safety profile of futibatinib in patients with advanced solid tumors, including intrahepatic cholangiocarcinoma (iCCA)ANNALS OF ONCOLOGY. Bd. 32. 2021 S. S378-S378
Gairing, Simon Johannes; Galle, Peter Robert; Schattenberg, Joern M. et al.
Portal Vein Thrombosis Is Associated with an Increased Incidence of Depression and Anxiety DisordersJOURNAL OF CLINICAL MEDICINE. Bd. 10. H. 23. 2021
Triantafyllias, Konstantinos; Cavagna, Lorenzo; Klonowski, Anna et al.
Possible misclassification of cardiovascular risk by SCORE in antisynthetase syndrome: results of the pilot multicenter study RI.CARDARHEUMATOLOGY. Bd. 60. H. 3. 2021 S. 1300-1312
Faustino, Larissa C.; Kahaly, George J.; Frommer, Lara et al.
Precision Medicine in Graves' Disease: CD40 Gene Variants Predict Clinical Response to an Anti-CD40 Monoclonal AntibodyFRONTIERS IN ENDOCRINOLOGY. Bd. 12. 2021
Scheiner, Bernhard; Pomej, Katharina; Kirstein, Martha M. et al.
Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy - the CRAFITY scoreWIENER KLINISCHE WOCHENSCHRIFT. Bd. 133. H. SUPPL 5. 2021 S. 179-179
Scheiner, Bernhard; Pomej, Katharina; Kirstein, Martha M. et al.
Predicting the outcome of patients with hepatocellular carcinoma treated with immunotherapy-the CRAFITY scoreJOURNAL OF HEPATOLOGY. Bd. 75. 2021 S. S236-S238
Hoppe, Elena; Lee, Alan Chun Hong; Hoppe, David et al.
Predictive Factors for Changes in Quality of Life after Steroid Treatment for Active Moderate-to-Severe Graves' Orbitopathy: A Prospective TrialEUROPEAN THYROID JOURNAL. Bd. 9. H. 6. 2021 S. 313-320
Biller, Beverly M. K.; Hoybye, Charlotte; Carroll, Paul et al.
Pregnancy outcomes in women receiving growth hormone replacement therapy enrolled in the NordiNet (R) International Outcome Study (IOS) and the American Norditropin (R) Studies: Web-Enabled Research (ANSWER) ProgramPITUITARY. Bd. 24. H. 4. 2021 S. 611-621
Mueller, Lukas; Hahn, Felix; Maehringer-Kunz, Aline et al.
Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolizationUNITED EUROPEAN GASTROENTEROLOGY JOURNAL. Bd. 10. H. 1. 2021 S. 41-53